Trastuzumab emtansine (T-DM1) plus docetaxel with or without pertuzumab in patients with HER2-positive locally advanced or metastatic breast cancer: Results from a phase Ib/IIa study

1. Martin, M.
2. Fumoleau, P.
3. Dewar, J.A.
4. Albanell, J.
5. Limentani, S.A.
6. Campone, M.
7. Chang, J.C.
8. Patre, M.
9. Strasak, A.
10. de Haas, S.L.
11. Xu, J.
12. Garcia-Saenz, J.A.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1093/ANNONC/MDW157 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus